July 16, 2007 - World Heart Corp. (WorldHeart), a developer of mechanical circulatory support systems, announced the animal implant of a the PediaFlow, a miniaturized, pediatric, ventricular assist device (VAD), which is the platform for a future minimally invasive adult VAD, intended to meet a large clinical need for earlier-stage heart failure patients.

July 13, 2007 - Biotronik announced that it recently completed the enrollment of the ProLimus I First-In-Man trial to test the safety and efficacy of its ProGenic Pimecrolimus eluting coronary stent system.

July 12, 2007 - TeraRecon announced it has achieved greater than 100 percent sales bookings growth for the U.S. and Canada in Q2 2007 in comparison with the same quarter in 2006, while also completing several notable enterprise installations of the Aquarius product suite.

July 13, 2007 – ScImage, a leading enterprise imaging and information management company, announced today that the company and its business partners have completed 36 new agreements for the company’s award winning PicomEnterprise solution to be installed or enhanced at more than fifty locations nationwide.

Navigational Ablation Catheter Features Microtensioning System
The EZ Steer NAV Bi-Directional Catheter is a navigational ablation catheter designed to give physicians improved range of motion, ease of use and technical finesse during procedures to eliminate abnormal heart rhythms. It’s now available for use with the Carto XP System, which provides real-time feedback in guiding the catheter to the target.

The FDA has cleared the Cordis Enterprise Vascular Reconstruction Device and Delivery System under the Humanitarian Device Exemption.

July 12, 2007 — GE Healthcare has released the latest version of Centricity Enterprise, an intelligent and integrated software suite of clinical and financial applications that is designed to improve patient care and increase collaboration between clinicians, providing a better overall healthcare environment.

A WALL STREET JOURNAL ONLINE NEWS ROUNDUP
July 11, 2007 - General Electric Co. and Abbott Laboratories announced they have terminated GE's $8.13 billion deal to buy Abbott's primary in-vitro and point-of-care diagnostics businesses.

In separate statements, the companies said they were unable to agree on "final terms and conditions" of the proposed deal. As a result, according to GE's statement, the companies "agreed it was in the best interests of both companies to mutually terminate their agreement and discussions."

The Acuity steerable left ventricular lead device is designed for cardiac resynchronization therapy defibrillators and cardiac resynchronization therapy pacemakers, both of which treat heart failure. The product features a deflectable tip for precise placement of the lead even in difficult-to-access branch vessels on the left side of the heart, according to the company.

The Sensei Robotic Catheter System and Artisan Control Catheter facilitate manipulation, positioning and control of mapping catheters during EP procedures.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now